

share
Kuguacin J CAS NO 1141453-65-7
Unit Price:
CAS No.:1141453-65-7
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Kuguacin J CAS NO 1141453-65-7 is a high-purity, specialized triterpenoid compound isolated from natural sources. This bioactive molecule is valued for its significant potential in pharmaceutical research and development, particularly in the study of metabolic and inflammatory pathways. It serves as a critical reference standard and intermediate for researchers and manufacturers in the pharmaceutical, biotechnology, and nutraceutical industries seeking to develop novel therapeutic agents.
Application
- Pharmaceutical Reference Standard: Used for the qualitative and quantitative analysis of herbal extracts and finished products in quality control laboratories.
- Bioactive Ingredient Research: Serves as a key intermediate or active component in R&D for new drugs targeting metabolic disorders and inflammation.
- Nutraceutical Formulation: Incorporated into high-end dietary supplements where standardized, pure bioactive compounds are required for efficacy and consistency.
- Academic & Clinical Research: Utilized in university and institutional studies to investigate pharmacological activities, mechanisms of action, and structure-activity relationships.
- Cosmeceutical Development: Applied in the research of advanced skincare products for its potential bioactive properties.
Basic Information
| Product Name | Kuguacin J |
| CAS No. | 1141453-65-7 |
| Molecular Formula | C30H48O3 |
| Molecular Weight | 456.7 g/mol |
| Synonyms | (23R,24S)-23,24-Epoxy-3β-hydroxycucurbita-5,25-dien-19-al; Kuguacin J; Kuguacine J; Cucurbitacin Triterpenoid Derivative; Momordica charantia Triterpene |
| EINECS | Contact for details |
Quality Control
Our Kuguacin J is produced under strict quality management protocols to ensure batch-to-batch consistency and high purity suitable for research applications. Each lot is accompanied by a comprehensive Certificate of Analysis (COA) detailing purity, identity, and impurity profiles. We support compliance with cGMP guidelines for active pharmaceutical ingredients (APIs) and reference standards.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive); ensure the container is sealed tightly after each use to prevent degradation from atmospheric moisture.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white powder |
| Identification (HPLC) | Conforms to reference standard |
| Identification (IR) | Conforms to structure |
| Assay (HPLC) | ≥ 98.0% |
| Loss on Drying | ≤ 2.0% |
| Residue on Ignition | ≤ 0.5% |
| Heavy Metals | ≤ 20 ppm |
| Related Substances (HPLC) | Total impurities ≤ 2.0% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Parkeol CAS NO 514-45-4


(S)-(-)-Limonene CAS NO 5989-54-8


Terpinen-4-Ol CAS NO 562-74-3


Cedrene CAS NO 11028-42-5


β-Pinene CAS NO 127-91-3


3-Carene CAS NO 13466-78-9


Farnesene CAS NO 502-61-4


Glycyrrhizic Acid CAS NO 1405-86-3


Asiaticoside CAS NO 16830-15-2


Valerenic Acid CAS NO 3569-10-6


Asiatic Acid CAS NO 464-92-6


Zerumbone CAS NO 471-05-6


Cantharidin CAS NO 56-25-7


Madecassic Acid CAS NO 18449-41-7


Squalene CAS NO 111-02-4


D-(+)-Camphoric Acid CAS NO 124-83-4


Taraxerol CAS NO 127-22-0


Pimaric Acid CAS NO 127-27-5


1,2,3,4,4A,4B,5,6,7,9,10,10A-Dodecahydro-7-Isopropyl-1,4A-Dimethylphenanthren-1-Methanol CAS NO 127-36-6


Nopol CAS NO 128-50-7
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






